Contribute Try STAT+ Today

Elizabeth Holmes was poised to become the next college-dropout-turned-tech-billionaire. But there was only one problem: Her technology didn’t work.

Holmes, the founder of the blood-testing company Theranos, will now finally stand trial for allegedly defrauding doctors, patients, and investors. She and her business partner and ex-boyfriend, Ramesh “Sunny” Balwani, were indicted by a federal grand jury in June 2018. The trial was originally scheduled for summer 2020, but was postponed multiple times because of the coronavirus pandemic and Holmes’ pregnancy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment